In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Evolus Inc (NASDAQ: EOLS) was $14.02 for the day, down -0.78% from the previous closing price of $14.13. In other words, the price has decreased by -$0.78 from its previous closing price. On the day, 0.92 million shares were traded. EOLS stock price reached its highest trading level at $14.16 during the session, while it also had its lowest trading level at $13.75.
Ratios:
Our analysis of EOLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.23 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 22.05 whereas as Long-Term Debt/Eq ratio is at 21.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on January 29, 2024, Upgraded its rating to Overweight and sets its target price to $16 from $10 previously.
On June 23, 2022, Needham started tracking the stock assigning a Buy rating and target price of $18.
Barclays Upgraded its Underweight to Equal Weight on May 12, 2022, whereas the target price for the stock was revised from $8 to $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 23 ’24 when Avelar Rui sold 2,252 shares for $10.85 per share. The transaction valued at 24,438 led to the insider holds 366,595 shares of the business.
Beaver Sandra sold 1,586 shares of EOLS for $17,211 on Dec 23 ’24. The Chief Financial Officer now owns 146,916 shares after completing the transaction at $10.85 per share. On Dec 23 ’24, another insider, MOATAZEDI DAVID, who serves as the insider of the company, sold 10,502 shares for $10.85 each. As a result, the insider received 113,967 and left with 522,847 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EOLS now has a Market Capitalization of 887767488 and an Enterprise Value of 932607360. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.57 while its Price-to-Book (P/B) ratio in mrq is 150.56. Its current Enterprise Value per Revenue stands at 3.756 whereas that against EBITDA is -35.498.
Stock Price History:
The Beta on a monthly basis for EOLS is 1.34, which has changed by 0.18341708 over the last 52 weeks, in comparison to a change of 0.24440956 over the same period for the S&P500. Over the past 52 weeks, EOLS has reached a high of $17.82, while it has fallen to a 52-week low of $9.25. The 50-Day Moving Average of the stock is 17.96%, while the 200-Day Moving Average is calculated to be 5.48%.
Shares Statistics:
EOLS traded an average of 673.93K shares per day over the past three months and 1006400 shares per day over the past ten days. A total of 63.25M shares are outstanding, with a floating share count of 54.70M. Insiders hold about 13.62% of the company’s shares, while institutions hold 78.91% stake in the company. Shares short for EOLS as of 1735603200 were 5400784 with a Short Ratio of 8.01, compared to 1732838400 on 5210222. Therefore, it implies a Short% of Shares Outstanding of 5400784 and a Short% of Float of 8.709999999999999.
Earnings Estimates
A detailed examination of Evolus Inc (EOLS) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.01, with high estimates of -$0.01 and low estimates of -$0.01.
Analysts are recommending an EPS of between -$0.26 and -$0.3 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.06, with 4.0 analysts recommending between $0.05 and -$0.21.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $79.01M to a low estimate of $78.99M. As of the current estimate, Evolus Inc’s year-ago sales were $61MFor the next quarter, 2 analysts are estimating revenue of $73.9M. There is a high estimate of $73.9M for the next quarter, whereas the lowest estimate is $73.9M.
A total of 4 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $266.34M, while the lowest revenue estimate was $266.3M, resulting in an average revenue estimate of $266.31M. In the same quarter a year ago, actual revenue was $202.09MBased on 6 analysts’ estimates, the company’s revenue will be $351.75M in the next fiscal year. The high estimate is $354.26M and the low estimate is $349.7M.
